secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0001104659-24-049529
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals prices $2.0M public offering of common stock at $3.30 per share
--------------------------------------------------------------------------------

- Underwritten public offering of 607,000 shares at $3.30/share; gross proceeds ~$2.0M before expenses.
- Underwriters granted 45-day option for up to 91,050 additional shares at same price to cover over-allotments.
- Company will issue to representative EF Hutton a warrant to purchase up to 30,350 shares (5% of shares sold) at $3.63/share.
- Net proceeds to be used for working capital, general corporate purposes, and potential repayment of Streeterville Capital note.
- Offering closed on April 19, 2024; shares sold under existing effective shelf registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924049529/0001104659-24-049529-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924049529/tm2412274d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-049529

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer